Litmus Test Awaits Emerging-Market Stocks After Seven-Week Rally
- Benchmark equity gauge up more than 17% since end-Sept.
- Year-end profit booking can lead to sharp correction: Rabobank
Photographer: Patrícia Monteiro/Bloomberg
This article is for subscribers only.
Emerging markets may have their work cut out sustaining one of their strongest final quarters in more than a decade.
Prospects for a U.S. stimulus windfall, a successful roll-out of Covid-19 vaccine programs, a commodity-price boom and even a possible Brexit trade deal were enough to keep the rally on course last week. Indexes of stocks, currencies and bonds registered their seventh successive weekly advance, taking the gain on the MSCI Inc. equity gauge since the end of September to more than 17% on Friday.